Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 18 | 2024 | 255 | 5.100 |
Why?
|
Neoplastic Stem Cells | 17 | 2019 | 143 | 4.650 |
Why?
|
Brain Neoplasms | 17 | 2021 | 763 | 3.580 |
Why?
|
Glioma | 15 | 2021 | 285 | 3.300 |
Why?
|
Chordoma | 8 | 2021 | 19 | 2.270 |
Why?
|
Caulobacter crescentus | 3 | 2019 | 9 | 1.420 |
Why?
|
Protein Phosphatase 2 | 3 | 2018 | 15 | 1.380 |
Why?
|
Meningeal Neoplasms | 2 | 2019 | 61 | 1.310 |
Why?
|
Meningioma | 2 | 2019 | 60 | 1.300 |
Why?
|
Signal Transduction | 15 | 2019 | 3241 | 1.270 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 2 | 2018 | 76 | 1.250 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2019 | 458 | 1.210 |
Why?
|
Piperazines | 2 | 2018 | 272 | 1.120 |
Why?
|
Cell Hypoxia | 3 | 2019 | 164 | 1.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2017 | 151 | 1.000 |
Why?
|
Repressor Proteins | 7 | 2019 | 403 | 0.970 |
Why?
|
Radiation Tolerance | 2 | 2018 | 168 | 0.970 |
Why?
|
Tumor Cells, Cultured | 11 | 2018 | 1041 | 0.950 |
Why?
|
Central Nervous System Neoplasms | 3 | 2020 | 81 | 0.940 |
Why?
|
Transcription Factors | 4 | 2019 | 1565 | 0.940 |
Why?
|
Escherichia coli | 2 | 2017 | 597 | 0.880 |
Why?
|
Gene Expression Regulation, Bacterial | 4 | 2019 | 204 | 0.860 |
Why?
|
DNA-Binding Proteins | 5 | 2017 | 1208 | 0.780 |
Why?
|
Dacarbazine | 3 | 2012 | 102 | 0.780 |
Why?
|
Antineoplastic Agents | 8 | 2018 | 2360 | 0.760 |
Why?
|
Tumor Hypoxia | 2 | 2017 | 29 | 0.760 |
Why?
|
Membrane Proteins | 3 | 2019 | 1196 | 0.750 |
Why?
|
ErbB Receptors | 4 | 2021 | 485 | 0.720 |
Why?
|
Tumor Microenvironment | 5 | 2024 | 418 | 0.720 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 22 | 0.720 |
Why?
|
Immunotherapy | 3 | 2019 | 629 | 0.710 |
Why?
|
Metals, Heavy | 1 | 2019 | 15 | 0.680 |
Why?
|
Mitochondria | 2 | 2019 | 535 | 0.670 |
Why?
|
Antibodies, Monoclonal, Humanized | 4 | 2020 | 930 | 0.660 |
Why?
|
Bevacizumab | 3 | 2016 | 281 | 0.650 |
Why?
|
Nanotubes | 1 | 2018 | 9 | 0.650 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 30 | 0.640 |
Why?
|
Cell Proliferation | 12 | 2018 | 1578 | 0.640 |
Why?
|
Metals, Rare Earth | 1 | 2017 | 2 | 0.640 |
Why?
|
Cell Culture Techniques | 4 | 2016 | 188 | 0.630 |
Why?
|
Gold | 1 | 2018 | 41 | 0.630 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 267 | 0.630 |
Why?
|
Digitoxin | 1 | 2017 | 3 | 0.620 |
Why?
|
Mice, SCID | 5 | 2019 | 252 | 0.620 |
Why?
|
Resting Phase, Cell Cycle | 1 | 2017 | 5 | 0.620 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 279 | 0.610 |
Why?
|
Carbonic Anhydrases | 1 | 2017 | 15 | 0.610 |
Why?
|
Neoplasm Proteins | 3 | 2019 | 532 | 0.600 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 125 | 0.590 |
Why?
|
Cell Line, Tumor | 12 | 2019 | 2426 | 0.590 |
Why?
|
Antigens, CD | 4 | 2015 | 458 | 0.590 |
Why?
|
STAT3 Transcription Factor | 2 | 2014 | 78 | 0.580 |
Why?
|
Mice | 18 | 2024 | 11352 | 0.580 |
Why?
|
Transcription, Genetic | 3 | 2019 | 1135 | 0.560 |
Why?
|
Benzazepines | 1 | 2016 | 89 | 0.560 |
Why?
|
Animals | 27 | 2024 | 26582 | 0.550 |
Why?
|
Proto-Oncogene Proteins | 1 | 2019 | 645 | 0.540 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2015 | 19 | 0.540 |
Why?
|
Bacterial Proteins | 2 | 2019 | 864 | 0.540 |
Why?
|
Humans | 56 | 2021 | 86643 | 0.530 |
Why?
|
Cell Separation | 1 | 2016 | 196 | 0.530 |
Why?
|
Loss of Heterozygosity | 1 | 2015 | 85 | 0.530 |
Why?
|
Transplantation, Heterologous | 3 | 2015 | 363 | 0.520 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 85 | 0.520 |
Why?
|
Biomarkers, Tumor | 4 | 2018 | 1464 | 0.510 |
Why?
|
Protein Kinases | 2 | 2013 | 209 | 0.510 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 128 | 0.500 |
Why?
|
Angiogenesis Inhibitors | 4 | 2012 | 311 | 0.500 |
Why?
|
Glycoproteins | 3 | 2011 | 234 | 0.490 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 2015 | 53 | 0.490 |
Why?
|
Neoplasm Transplantation | 2 | 2012 | 391 | 0.490 |
Why?
|
Serine | 1 | 2014 | 99 | 0.470 |
Why?
|
Hypothalamic Neoplasms | 1 | 2012 | 2 | 0.440 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 373 | 0.440 |
Why?
|
Escherichia coli Proteins | 1 | 2013 | 179 | 0.420 |
Why?
|
Peptides | 3 | 2011 | 639 | 0.420 |
Why?
|
Spinal Cord Neoplasms | 1 | 2012 | 48 | 0.410 |
Why?
|
RNA, Small Interfering | 4 | 2019 | 547 | 0.410 |
Why?
|
Vitamin A | 1 | 2011 | 27 | 0.400 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2012 | 137 | 0.400 |
Why?
|
Vaccines | 2 | 2024 | 80 | 0.400 |
Why?
|
Disease Models, Animal | 4 | 2018 | 2232 | 0.380 |
Why?
|
Frontal Lobe | 1 | 2011 | 130 | 0.380 |
Why?
|
von Hippel-Lindau Disease | 2 | 2007 | 17 | 0.370 |
Why?
|
Cerebellar Neoplasms | 2 | 2007 | 36 | 0.370 |
Why?
|
AC133 Antigen | 4 | 2017 | 9 | 0.360 |
Why?
|
Muir-Torre Syndrome | 1 | 2008 | 4 | 0.340 |
Why?
|
RNA Interference | 3 | 2019 | 369 | 0.340 |
Why?
|
Apoptosis | 5 | 2018 | 1683 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2017 | 407 | 0.320 |
Why?
|
Spheroids, Cellular | 2 | 2018 | 31 | 0.310 |
Why?
|
Cell Survival | 6 | 2018 | 969 | 0.310 |
Why?
|
Hemangioblastoma | 1 | 2007 | 12 | 0.300 |
Why?
|
Multipotent Stem Cells | 1 | 2007 | 19 | 0.300 |
Why?
|
Phosphorylation | 4 | 2017 | 1106 | 0.300 |
Why?
|
Stem Cells | 4 | 2010 | 351 | 0.290 |
Why?
|
Female | 18 | 2020 | 44532 | 0.290 |
Why?
|
Uranium | 2 | 2017 | 7 | 0.290 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 187 | 0.280 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 1047 | 0.280 |
Why?
|
Astrocytoma | 3 | 2012 | 82 | 0.280 |
Why?
|
Hypoxia | 1 | 2011 | 641 | 0.270 |
Why?
|
Neoplasms | 3 | 2018 | 2898 | 0.270 |
Why?
|
Nuclear Proteins | 2 | 2008 | 696 | 0.270 |
Why?
|
Middle Aged | 13 | 2020 | 25028 | 0.260 |
Why?
|
Cell Differentiation | 5 | 2017 | 1458 | 0.260 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 3 | 2017 | 115 | 0.250 |
Why?
|
Stress, Physiological | 2 | 2017 | 227 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2019 | 182 | 0.240 |
Why?
|
Male | 20 | 2021 | 40965 | 0.230 |
Why?
|
Cell Movement | 2 | 2018 | 758 | 0.230 |
Why?
|
Neurons | 7 | 2012 | 1546 | 0.230 |
Why?
|
Catheters, Indwelling | 2 | 2007 | 110 | 0.230 |
Why?
|
Biomarkers | 5 | 2018 | 1718 | 0.230 |
Why?
|
Protein Transport | 3 | 2017 | 411 | 0.220 |
Why?
|
Cerebral Ventricles | 1 | 2002 | 76 | 0.220 |
Why?
|
Programmed Cell Death 1 Receptor | 2 | 2020 | 159 | 0.210 |
Why?
|
Telomerase | 1 | 2021 | 55 | 0.200 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2012 | 104 | 0.200 |
Why?
|
Methotrexate | 1 | 2002 | 249 | 0.200 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 236 | 0.190 |
Why?
|
Meningitis | 1 | 2020 | 20 | 0.190 |
Why?
|
Thymoma | 1 | 2020 | 30 | 0.190 |
Why?
|
Gene Expression | 3 | 2018 | 1284 | 0.190 |
Why?
|
Thymus Neoplasms | 1 | 2020 | 41 | 0.190 |
Why?
|
Lymphoma | 1 | 2002 | 262 | 0.180 |
Why?
|
Ras Homolog Enriched in Brain Protein | 1 | 2019 | 1 | 0.180 |
Why?
|
Staphylococcal Infections | 1 | 2002 | 255 | 0.180 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 41 | 0.180 |
Why?
|
Monitoring, Immunologic | 1 | 2019 | 17 | 0.170 |
Why?
|
Heterografts | 1 | 2019 | 98 | 0.170 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2019 | 42 | 0.170 |
Why?
|
Immunohistochemistry | 5 | 2018 | 1753 | 0.170 |
Why?
|
Receptors, Dopamine D5 | 1 | 2018 | 1 | 0.170 |
Why?
|
Dopamine D2 Receptor Antagonists | 1 | 2018 | 7 | 0.170 |
Why?
|
Microdialysis | 1 | 2019 | 32 | 0.170 |
Why?
|
Biological Transport, Active | 1 | 2019 | 102 | 0.170 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 72 | 0.170 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 552 | 0.170 |
Why?
|
Radiosurgery | 2 | 2012 | 272 | 0.170 |
Why?
|
Organelle Biogenesis | 1 | 2018 | 5 | 0.170 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 10 | 0.160 |
Why?
|
Receptors, Dopamine D2 | 1 | 2018 | 57 | 0.160 |
Why?
|
Nestin | 1 | 2018 | 18 | 0.160 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 28 | 0.160 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 68 | 0.160 |
Why?
|
Adult | 10 | 2021 | 25648 | 0.160 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2020 | 261 | 0.160 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 365 | 0.160 |
Why?
|
Mice, Nude | 2 | 2017 | 790 | 0.160 |
Why?
|
Lanthanoid Series Elements | 1 | 2017 | 11 | 0.160 |
Why?
|
Adsorption | 1 | 2017 | 54 | 0.160 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 62 | 0.160 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 937 | 0.160 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 166 | 0.150 |
Why?
|
B7-H1 Antigen | 1 | 2019 | 250 | 0.150 |
Why?
|
Cell Self Renewal | 1 | 2017 | 18 | 0.150 |
Why?
|
Gaucher Disease | 2 | 2007 | 4 | 0.150 |
Why?
|
Endocytosis | 1 | 2018 | 177 | 0.150 |
Why?
|
Protein Binding | 2 | 2018 | 1456 | 0.150 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2017 | 45 | 0.150 |
Why?
|
Proteasome Inhibitors | 1 | 2016 | 51 | 0.150 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 1686 | 0.150 |
Why?
|
Copper | 1 | 2017 | 71 | 0.150 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 480 | 0.140 |
Why?
|
Dexamethasone | 1 | 2018 | 326 | 0.140 |
Why?
|
Stem Cell Niche | 1 | 2016 | 21 | 0.140 |
Why?
|
Zinc | 1 | 2017 | 91 | 0.140 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 100 | 0.140 |
Why?
|
Oxidative Stress | 1 | 2019 | 447 | 0.140 |
Why?
|
Energy Metabolism | 1 | 2018 | 271 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2017 | 148 | 0.140 |
Why?
|
Neurosurgical Procedures | 2 | 2016 | 213 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2013 | 57 | 0.140 |
Why?
|
Ligands | 1 | 2017 | 433 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 8 | 2020 | 3362 | 0.140 |
Why?
|
Enzyme Activation | 1 | 2017 | 692 | 0.140 |
Why?
|
Surgery, Computer-Assisted | 2 | 2007 | 99 | 0.140 |
Why?
|
Angiopoietin-2 | 2 | 2013 | 15 | 0.140 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 363 | 0.140 |
Why?
|
Paresis | 2 | 2012 | 15 | 0.140 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 257 | 0.130 |
Why?
|
Epidermal Growth Factor | 2 | 2013 | 119 | 0.130 |
Why?
|
Rats | 6 | 2012 | 3990 | 0.130 |
Why?
|
Intracranial Aneurysm | 1 | 2016 | 158 | 0.130 |
Why?
|
Brain | 4 | 2010 | 2216 | 0.130 |
Why?
|
Chemoradiotherapy | 1 | 2017 | 301 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2015 | 145 | 0.130 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2015 | 22 | 0.130 |
Why?
|
Cytokines | 1 | 2019 | 776 | 0.130 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 353 | 0.130 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 136 | 0.130 |
Why?
|
Disease-Free Survival | 1 | 2017 | 1204 | 0.130 |
Why?
|
Collagen Type I | 1 | 2015 | 62 | 0.130 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 1384 | 0.130 |
Why?
|
DNA Transposable Elements | 1 | 2015 | 169 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 2438 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 1 | 2016 | 292 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 376 | 0.120 |
Why?
|
bcl-X Protein | 1 | 2014 | 52 | 0.120 |
Why?
|
Treatment Outcome | 3 | 2019 | 7993 | 0.120 |
Why?
|
Hydroquinones | 1 | 2013 | 8 | 0.120 |
Why?
|
DNA Footprinting | 1 | 2013 | 18 | 0.120 |
Why?
|
Regulon | 1 | 2013 | 16 | 0.120 |
Why?
|
Deoxyribonuclease I | 1 | 2013 | 28 | 0.120 |
Why?
|
Benzoquinones | 1 | 2013 | 27 | 0.120 |
Why?
|
Bacteria | 1 | 2017 | 447 | 0.120 |
Why?
|
Biopsy | 2 | 2020 | 1163 | 0.120 |
Why?
|
Brain Stem | 2 | 2020 | 165 | 0.120 |
Why?
|
Quinazolines | 1 | 2015 | 220 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 1197 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 456 | 0.110 |
Why?
|
Janus Kinase 1 | 1 | 2013 | 15 | 0.110 |
Why?
|
Carbon | 1 | 2013 | 80 | 0.110 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2010 | 30 | 0.110 |
Why?
|
Phenotype | 2 | 2017 | 2378 | 0.110 |
Why?
|
Ciliary Neurotrophic Factor Receptor alpha Subunit | 1 | 2012 | 1 | 0.110 |
Why?
|
SOXB1 Transcription Factors | 1 | 2012 | 21 | 0.110 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2013 | 102 | 0.110 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 78 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 1565 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 689 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 860 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 199 | 0.110 |
Why?
|
Brain Edema | 1 | 2012 | 50 | 0.100 |
Why?
|
Cerebral Angiography | 1 | 2012 | 196 | 0.100 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 138 | 0.100 |
Why?
|
Astrocytes | 1 | 2012 | 139 | 0.100 |
Why?
|
Carotenoids | 1 | 2011 | 14 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2010 | 322 | 0.100 |
Why?
|
Hydrocephalus | 1 | 2012 | 101 | 0.100 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 2 | 2010 | 23 | 0.100 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 220 | 0.100 |
Why?
|
Binding Sites | 1 | 2013 | 1098 | 0.100 |
Why?
|
Proteomics | 2 | 2009 | 212 | 0.100 |
Why?
|
Recombinant Proteins | 1 | 2012 | 1014 | 0.100 |
Why?
|
Up-Regulation | 2 | 2012 | 712 | 0.100 |
Why?
|
Cholera Toxin | 1 | 2010 | 21 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 589 | 0.090 |
Why?
|
beta Catenin | 1 | 2012 | 251 | 0.090 |
Why?
|
Child | 3 | 2021 | 6927 | 0.090 |
Why?
|
Peptide Mapping | 1 | 2009 | 26 | 0.090 |
Why?
|
Mutation | 3 | 2021 | 3968 | 0.090 |
Why?
|
Blotting, Western | 2 | 2012 | 782 | 0.090 |
Why?
|
Hyaluronan Receptors | 1 | 2009 | 36 | 0.090 |
Why?
|
Cell Growth Processes | 1 | 2009 | 83 | 0.090 |
Why?
|
Protein Array Analysis | 2 | 2007 | 50 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 70 | 0.090 |
Why?
|
Receptors, CXCR4 | 1 | 2009 | 44 | 0.090 |
Why?
|
Hippocampus | 1 | 2012 | 442 | 0.090 |
Why?
|
Fetus | 1 | 2010 | 226 | 0.090 |
Why?
|
MicroRNAs | 1 | 2014 | 534 | 0.080 |
Why?
|
MutL Protein Homolog 1 | 1 | 2008 | 33 | 0.080 |
Why?
|
MutS Homolog 2 Protein | 1 | 2008 | 30 | 0.080 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 86 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2010 | 233 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 262 | 0.080 |
Why?
|
Craniotomy | 1 | 2009 | 88 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 468 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2012 | 2818 | 0.080 |
Why?
|
Chromosome Deletion | 1 | 2009 | 229 | 0.080 |
Why?
|
Aging | 1 | 2012 | 691 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 879 | 0.080 |
Why?
|
Time Factors | 1 | 2016 | 5210 | 0.080 |
Why?
|
Chromogranin B | 1 | 2007 | 1 | 0.080 |
Why?
|
Dopamine | 1 | 2009 | 275 | 0.080 |
Why?
|
Pons | 1 | 2007 | 24 | 0.080 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2007 | 8 | 0.080 |
Why?
|
Gastric Bypass | 1 | 2009 | 110 | 0.080 |
Why?
|
Okadaic Acid | 1 | 2007 | 9 | 0.080 |
Why?
|
CD13 Antigens | 1 | 2007 | 5 | 0.080 |
Why?
|
Cell Degranulation | 1 | 2007 | 14 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 639 | 0.080 |
Why?
|
Glucosylceramidase | 1 | 2006 | 2 | 0.070 |
Why?
|
Pheochromocytoma | 1 | 2007 | 49 | 0.070 |
Why?
|
Convection | 1 | 2006 | 12 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 87 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 302 | 0.070 |
Why?
|
Perfusion | 1 | 2007 | 203 | 0.070 |
Why?
|
Pedigree | 1 | 2008 | 966 | 0.070 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2007 | 80 | 0.070 |
Why?
|
Tretinoin | 1 | 2007 | 126 | 0.070 |
Why?
|
Drug Synergism | 1 | 2007 | 303 | 0.070 |
Why?
|
Young Adult | 2 | 2015 | 5976 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2009 | 225 | 0.070 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 61 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 2601 | 0.070 |
Why?
|
Neoplasm Grading | 2 | 2018 | 357 | 0.060 |
Why?
|
Primates | 1 | 2006 | 151 | 0.060 |
Why?
|
Dendritic Cells | 2 | 2024 | 425 | 0.060 |
Why?
|
Haplotypes | 1 | 2005 | 642 | 0.060 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 262 | 0.060 |
Why?
|
Immunity | 1 | 2024 | 136 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 3 | 2012 | 1219 | 0.050 |
Why?
|
Aged | 2 | 2020 | 18415 | 0.050 |
Why?
|
Time | 1 | 2002 | 77 | 0.050 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2002 | 6 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2012 | 2207 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2002 | 64 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2021 | 17 | 0.050 |
Why?
|
Receptor, TIE-2 | 2 | 2010 | 15 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 559 | 0.050 |
Why?
|
T-Box Domain Proteins | 1 | 2021 | 118 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2007 | 3640 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 46 | 0.040 |
Why?
|
Cell Division | 2 | 2011 | 696 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 263 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 316 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2019 | 121 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 49 | 0.040 |
Why?
|
Electron Transport Complex I | 1 | 2018 | 28 | 0.040 |
Why?
|
Drug Discovery | 1 | 2019 | 103 | 0.040 |
Why?
|
Ipilimumab | 1 | 2018 | 58 | 0.040 |
Why?
|
Drug Resistance | 1 | 2018 | 256 | 0.040 |
Why?
|
Imidazoles | 1 | 2018 | 162 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 434 | 0.040 |
Why?
|
CTLA-4 Antigen | 1 | 2018 | 135 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 183 | 0.040 |
Why?
|
Glycolysis | 1 | 2018 | 129 | 0.040 |
Why?
|
Adolescent | 2 | 2007 | 8981 | 0.040 |
Why?
|
DNA Damage | 1 | 2019 | 366 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2019 | 444 | 0.040 |
Why?
|
DNA Repair | 1 | 2019 | 356 | 0.040 |
Why?
|
HeLa Cells | 1 | 2018 | 498 | 0.040 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 20 | 0.040 |
Why?
|
Pyridines | 1 | 2018 | 310 | 0.040 |
Why?
|
Ubiquitination | 1 | 2016 | 67 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2021 | 1823 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 113 | 0.040 |
Why?
|
Electroencephalography | 1 | 2020 | 709 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2018 | 615 | 0.030 |
Why?
|
Truth Disclosure | 1 | 1996 | 87 | 0.030 |
Why?
|
Disclosure | 1 | 1996 | 108 | 0.030 |
Why?
|
Pyrimidines | 1 | 2018 | 370 | 0.030 |
Why?
|
Medical Errors | 1 | 1996 | 115 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2016 | 163 | 0.030 |
Why?
|
Mutagenesis | 1 | 2015 | 199 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2015 | 236 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2015 | 139 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 878 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2018 | 1939 | 0.030 |
Why?
|
NF-kappa B | 1 | 2016 | 444 | 0.030 |
Why?
|
Gene Dosage | 1 | 2014 | 207 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2007 | 8489 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 78 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 592 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 329 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 61 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 1313 | 0.030 |
Why?
|
Genetic Loci | 1 | 2014 | 250 | 0.030 |
Why?
|
Cell Count | 1 | 2012 | 195 | 0.030 |
Why?
|
Neuroglia | 1 | 2012 | 104 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2012 | 58 | 0.030 |
Why?
|
Solubility | 1 | 2012 | 177 | 0.030 |
Why?
|
Down-Regulation | 1 | 2014 | 504 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2012 | 104 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 1056 | 0.030 |
Why?
|
Disease Progression | 1 | 2016 | 1531 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 1376 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 92 | 0.030 |
Why?
|
Headache | 1 | 2012 | 73 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2009 | 2705 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2012 | 510 | 0.020 |
Why?
|
Laminin | 1 | 2011 | 85 | 0.020 |
Why?
|
Mitosis | 1 | 2011 | 153 | 0.020 |
Why?
|
Prognosis | 1 | 2018 | 3679 | 0.020 |
Why?
|
Transcriptome | 1 | 2015 | 580 | 0.020 |
Why?
|
Steroids | 1 | 2012 | 177 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 1920 | 0.020 |
Why?
|
Protein Phosphatase 1 | 1 | 2010 | 34 | 0.020 |
Why?
|
Acetylation | 1 | 2010 | 121 | 0.020 |
Why?
|
Cell Lineage | 1 | 2011 | 273 | 0.020 |
Why?
|
Haplorhini | 1 | 2010 | 81 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 2009 | 39 | 0.020 |
Why?
|
Electrophoresis, Capillary | 1 | 2009 | 12 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2010 | 30 | 0.020 |
Why?
|
Chromatography, Ion Exchange | 1 | 2009 | 34 | 0.020 |
Why?
|
Base Sequence | 1 | 2014 | 2330 | 0.020 |
Why?
|
Models, Biological | 1 | 2016 | 1749 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 427 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2010 | 80 | 0.020 |
Why?
|
Cytoprotection | 1 | 2009 | 47 | 0.020 |
Why?
|
Blood Vessels | 1 | 2009 | 94 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2009 | 188 | 0.020 |
Why?
|
Organ Specificity | 1 | 2009 | 258 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2009 | 192 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 165 | 0.020 |
Why?
|
Models, Neurological | 1 | 2012 | 405 | 0.020 |
Why?
|
Cell Death | 1 | 2009 | 256 | 0.020 |
Why?
|
Histones | 1 | 2010 | 311 | 0.020 |
Why?
|
Dissection | 1 | 2008 | 42 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 379 | 0.020 |
Why?
|
Cryopreservation | 1 | 2008 | 69 | 0.020 |
Why?
|
Facial Paralysis | 1 | 2007 | 17 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 503 | 0.020 |
Why?
|
Catecholamines | 1 | 2007 | 88 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2007 | 82 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 27 | 0.020 |
Why?
|
Simian virus 40 | 1 | 2006 | 35 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2007 | 261 | 0.020 |
Why?
|
HLA-DR Serological Subtypes | 1 | 2005 | 1 | 0.020 |
Why?
|
HLA-DRB5 Chains | 1 | 2005 | 1 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 3092 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2007 | 212 | 0.020 |
Why?
|
HLA-DRB1 Chains | 1 | 2005 | 28 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 1204 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2006 | 157 | 0.020 |
Why?
|
DNA, Viral | 1 | 2006 | 265 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 307 | 0.020 |
Why?
|
Interferon-beta | 1 | 2005 | 125 | 0.020 |
Why?
|
Central Nervous System | 1 | 2005 | 151 | 0.020 |
Why?
|
Thymus Gland | 1 | 2005 | 195 | 0.020 |
Why?
|
Radiography | 1 | 2006 | 813 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2006 | 459 | 0.020 |
Why?
|
Transfection | 1 | 2005 | 896 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 679 | 0.010 |
Why?
|
Lymphocytes | 1 | 2005 | 464 | 0.010 |
Why?
|
Contrast Media | 1 | 2007 | 1078 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2007 | 2379 | 0.010 |
Why?
|
Infant | 1 | 2006 | 3046 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 1981 | 0.010 |
Why?
|
Compensation and Redress | 1 | 1996 | 4 | 0.010 |
Why?
|
Jurisprudence | 1 | 1996 | 25 | 0.010 |
Why?
|
Liability, Legal | 1 | 1996 | 32 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1996 | 181 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 1996 | 379 | 0.010 |
Why?
|
Internal Medicine | 1 | 1996 | 347 | 0.010 |
Why?
|
United States | 1 | 1996 | 6672 | 0.000 |
Why?
|